biotherapy

(redirected from biotherapies)
Also found in: Dictionary, Encyclopedia.

modifier

 [mod´ĭ-fi-er]
1. an agent or method that causes something else to change.
biologic response modifier (BRM) (biological response modifier) a method or agent, such as a cytokine, monoclonal antibody, or vaccine, that alters host-tumor interaction. This is usually accomplished by amplifying the antitumor mechanisms of the immune system, but it also may be effected by mechanisms that affect host or tumor cell characteristics, either directly or indirectly. Called also biomodulator.
problem modifier on level three of the problem classification scheme of the omaha system, either of the two sets of terms used in conjunction with client problems, allowing the nurse to identify ownership of the problem and its degree of severity in relation to client interest, risk factors, and signs or symptoms.

biotherapy

/bio·ther·a·py/ (-ther´ah-pe) biological therapy.

biotherapy

(bī′ō-thĕr′ə-pē)
n. pl. biothera·pies
Treatment of disease with biologics, such as certain drugs, vaccines, or antitoxins.

biotherapy

a type of cancer therapy that uses agents to stimulate the body's own immune system to kill cancer. Examples include interleukins, interferons, and hematopoietic growth factors. The term is sometimes used interchangeably with targeted therapy. See also immunotherapy.

biotherapy

A highly nonspecific term for any treatment of any condition with anything that is or was at some point alive.

Alternative medicine
The term biotherapy has been utilised by a number of complementary and alternative medicine providers and will have ad hoc definitions according to the purveyor of the individual therapy.

Mainstream medicine
(1) Immunotherapy, see there.
(2) Treatment with genetically engineered products.
(3) The use of organ extracts in managing a condition—e.g., thyroid tissue extracts.
(4) The International Biotherapy Society lists maggot debridement therapy, hirudotherapy, apitherapy and ichthiotherapy as forms of biotherapy.
References in periodicals archive ?
Using its expertise in IVD and autoimmunity, from development phase to commercialization through regulation affair process, Theradiag will now be focusing its development strategy on theranostic tests to monitor biotherapies.
has implemented its Electronic Laboratory Notebook (ELN) solution at its Research and Development Department at the CSL Biotherapies, Broadmeadows site.
Breakout Session: Innovations and Opportunities in Vaccines Session ID 1877: New Defenses Against Old Enemies: Vaccines and Biotherapies for Bacterial Infection When: Tuesday, April 23, 2013, 9:00 - 10:15 AM Where: McCormick Place, Room S402A
CSL Biotherapies is proud to now be in a position to help in protecting this most vulnerable population of Americans.
CSL Biotherapies and its parent company, CSL Limited (ASX:CSL), one of the world's leading manufacturers of influenza vaccine, have reached an agreement with Merck & Co.
CSL Biotherapies has announced the initiation of the company's first U.
Pending approval of that application, CSL Biotherapies will introduce its influenza vaccine to the U.
CSL Biotherapies, a subsidiary of CSL Limited, one of the world's leading manufacturers of influenza vaccine, announced today that the U.
June 5 /PRNewswire/ -- Enrollment will begin for a pivotal influenza vaccine clinical trial sponsored by the National Institutes of Health (NIH), CSL Biotherapies announced today.
CSL Biotherapies plans to deliver more than eight million doses of the vaccine, the majority of which will be in single-dose, thimerosal-free, pre-filled syringes.
Through use of the right phage strains, and in the right amounts, Exponential Biotherapies has developed a "green" approach to controlling bacterial pathogens in the food supply.